These vascularised microfluidic tumour microenvironments were not only used to investigate the metabolic functions of cancer cells in the presence of vascular networks, but also assessed the viability of multiple chemotherapeutic drugs in their role of regressing vascular formation via the targeting of VEGF and PDGF receptors in vitro. Here, VEGFA is linked to neoplasm.